About 35,000 people are diagnosed with cancers of the mouth and oropharynx in the United States each year. Oral cancers are much more common in other countries, especially Hungary and France, and some 480,000 cases are diagnosed annually worldwide. Almost all oral cancers occur in squamous cells, which line the mouth and oropharynx. These are called squamous cell carcinomas.
Mouth cancer occurs most commonly under the tongue, the floor of the mouth and the lips. It can also begin in the gums, teeth, salivary glands, the lining of the lips and cheeks, the roof of the mouth and behind the wisdom teeth.
Oropharynx cancer, also known as oropharyngeal cancer, starts in
the area just behind the mouth (oropharynx), but can also occur in the
back of the tongue, the back of the mouth and the uvula, the tonsils and
the back and side walls of the throat.
More than half of patients are diagnosed after the cancer has spread to other areas of the body. The chances of successful treatment of oral cancers are highest when it is found early.
Oral Cancer Screening
At our office we offer Identafi® 3000 ultra, an oral cancer screening method created by MD Anderson Cancer Center.
Trimira’s® new Identafi® 3000 ultra uses the Identafi® Multi-Spectral Fluorescence and Reflectance technology to enhance visualization of mucosal abnormalities such as oral cancer or premalignant dysplasia that may not be apparent to the naked eye. But unlike other fluorescence technologies and dye systems, the Identafi® 3000 ultra is Multi-Spectral with three distinct color wavelengths, making it easier to distinguish lesion morphology and vasculature thereby reducing false positives. This oral cancer screening method is the best way to achieve early detection.